Exogenesis Corporation

Exogenesis Corporation is a leading company specializing in nanotechnology research, dedicated to advancing nanoscale surface modification and control technologies. With a focus on enhancing the safety and performance of implantable medical devices, Exogenesis Corporation also improves the performance of optics, glass, and various substrates used in the laser, memory, and semiconductor industries.

Exogenesis Corporation's innovative NanoAccel technology uniquely modifies surfaces at the atomic level without the need for coatings or additives. Originally developed for nanoscale surface processing of semiconductors and opto-electronic devices, the NanoAccel Gas Cluster Ion Beam (GCIB) technology now extends its capabilities to biomedical applications through exclusive worldwide rights. Complementing GCIB, Exogenesis has also developed an Accelerated Neutral Atom Beam technology, further solidifying its position at the forefront of nanotechnology. The primary address of Exogenesis Corporation is 20 Fortune Drive, Billerica, MA 01821, US.

Exogenesis Corporation continues to explore opportunities for commercializing the NanoAccel process, driving innovation and delivering cutting-edge solutions across multiple sectors. Exogenesis Corporation is committed to pushing the boundaries of nanotechnology and providing valuable advancements to its partners and clients. We invite the manager of Exogenesis Corporation to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and reach.